233 related articles for article (PubMed ID: 15567284)
1. Acyclovir prodrug for the intestinal di/tri-peptide transporter PEPT1: comparison of in vivo bioavailability in rats and transport in Caco-2 cells.
Thomsen AE; Christensen MS; Bagger MA; Steffansen B
Eur J Pharm Sci; 2004 Dec; 23(4-5):319-25. PubMed ID: 15567284
[TBL] [Abstract][Full Text] [Related]
2. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, transport and pharmacokinetics of 5'-amino acid ester prodrugs of 1-beta-D-arabinofuranosylcytosine.
Sun Y; Sun J; Shi S; Jing Y; Yin S; Chen Y; Li G; Xu Y; He Z
Mol Pharm; 2009; 6(1):315-25. PubMed ID: 19115956
[TBL] [Abstract][Full Text] [Related]
4. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.
Anand BS; Patel J; Mitra AK
J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834
[TBL] [Abstract][Full Text] [Related]
5. Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2.
Ganapathy ME; Huang W; Wang H; Ganapathy V; Leibach FH
Biochem Biophys Res Commun; 1998 May; 246(2):470-5. PubMed ID: 9610386
[TBL] [Abstract][Full Text] [Related]
6. Pyrimidine and nucleoside gamma-esters of L-Glu-Sar: synthesis, stability and interaction with hPEPT1.
Eriksson AH; Elm PL; Begtrup M; Brodin B; Nielsen R; Steffansen B
Eur J Pharm Sci; 2005 May; 25(1):145-54. PubMed ID: 15854810
[TBL] [Abstract][Full Text] [Related]
7. Prodrugs of purine and pyrimidine analogues for the intestinal di/tri-peptide transporter PepT1: affinity for hPepT1 in Caco-2 cells, drug release in aqueous media and in vitro metabolism.
Thomsen AE; Friedrichsen GM; Sørensen AH; Andersen R; Nielsen CU; Brodin B; Begtrup M; Frokjaer S; Steffansen B
J Control Release; 2003 Jan; 86(2-3):279-92. PubMed ID: 12526824
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of novel dipeptide ester prodrugs of acyclovir after oral administration: intestinal absorption and liver metabolism.
Anand BS; Katragadda S; Mitra AK
J Pharmacol Exp Ther; 2004 Nov; 311(2):659-67. PubMed ID: 15226381
[TBL] [Abstract][Full Text] [Related]
9. PEPT1 involved in the uptake and transepithelial transport of cefditoren in vivo and in vitro.
Zhang Q; Liu Q; Wu J; Wang C; Peng J; Ma X; Liu K
Eur J Pharmacol; 2009 Jun; 612(1-3):9-14. PubMed ID: 19371738
[TBL] [Abstract][Full Text] [Related]
10. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line.
Guo A; Hu P; Balimane PV; Leibach FH; Sinko PJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):448-54. PubMed ID: 10087037
[TBL] [Abstract][Full Text] [Related]
11. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.
Gupta D; Varghese Gupta S; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
Mol Pharm; 2013 Feb; 10(2):512-22. PubMed ID: 23244438
[TBL] [Abstract][Full Text] [Related]
12. Polarized efflux of mono- and diacid metabolites of ME3229, an ester-type prodrug of a glycoprotein IIb/IIIa receptor antagonist, in rat small intestine.
Okudaira N; Komiya I; Sugiyama Y
J Pharmacol Exp Ther; 2000 Nov; 295(2):717-23. PubMed ID: 11046110
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of analogs of L-valacyclovir and determination of their substrate activity for the oligopeptide transporter in Caco-2 cells.
Friedrichsen GM; Chen W; Begtrup M; Lee CP; Smith PL; Borchardt RT
Eur J Pharm Sci; 2002 Jul; 16(1-2):1-13. PubMed ID: 12113886
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the effect of ethanol's toxic metabolite acetaldehyde on the gastrointestinal oligopeptide transporter, PEPT1: in vitro and in vivo studies.
Fisher SJ; Lee IJ; Swaan PW; Eddington ND
Alcohol Clin Exp Res; 2008 Jan; 32(1):162-70. PubMed ID: 18028524
[TBL] [Abstract][Full Text] [Related]
15. Uptake, transport and regulation of JBP485 by PEPT1 in vitro and in vivo.
Liu Z; Wang C; Liu Q; Meng Q; Cang J; Mei L; Kaku T; Liu K
Peptides; 2011 Apr; 32(4):747-54. PubMed ID: 21262302
[TBL] [Abstract][Full Text] [Related]
16. Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir.
Palmberger TF; Hombach J; Bernkop-Schnürch A
Int J Pharm; 2008 Feb; 348(1-2):54-60. PubMed ID: 17716840
[TBL] [Abstract][Full Text] [Related]
17. Oseltamivir (tamiflu) is a substrate of peptide transporter 1.
Ogihara T; Kano T; Wagatsuma T; Wada S; Yabuuchi H; Enomoto S; Morimoto K; Shirasaka Y; Kobayashi S; Tamai I
Drug Metab Dispos; 2009 Aug; 37(8):1676-81. PubMed ID: 19439487
[TBL] [Abstract][Full Text] [Related]
18. Effect of chitosan glutamate, carbomer 974P, and EDTA on the in vitro Caco-2 permeability and oral pharmacokinetic profile of acyclovir in rats.
Merzlikine A; Rotter C; Rago B; Poe J; Christoffersen C; Thomas VH; Troutman M; El-Kattan A
Drug Dev Ind Pharm; 2009 Sep; 35(9):1082-91. PubMed ID: 19294548
[TBL] [Abstract][Full Text] [Related]
19. Transport of levovirin prodrugs in the human intestinal Caco-2 cell line.
Li F; Hong L; Mau CI; Chan R; Hendricks T; Dvorak C; Yee C; Harris J; Alfredson T
J Pharm Sci; 2006 Jun; 95(6):1318-25. PubMed ID: 16634069
[TBL] [Abstract][Full Text] [Related]
20. Conjugation of dipeptide to fluorescent dyes enhances its affinity for a dipeptide transporter (PEPT1) in human intestinal Caco-2 cells.
Abe H; Satoh M; Miyauchi S; Shuto S; Matsuda A; Kamo N
Bioconjug Chem; 1999; 10(1):24-31. PubMed ID: 9893960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
